Moreover, joint inflammation in RA patients is associated with hydrogen peroxide (H2O2) production, which might be mediated by MAO-B and mitigated by antioxidant administration, suggesting that MAO-B could be an effective therapeutic target for RA17,19,20. This evidence concerns the gene MAOB and rheumatoid arthritis.